(Press-News.org) Researchers led by investigators at Mass General Brigham and Massachusetts Institute of Technology have validated an ingestible capsule in preclinical models for the diagnosis of acute mesenteric ischemia, a condition caused by blocked or reduced blood flow to the intestines. The research is published in Science Robotics.
Acute mesenteric ischemia accounts for less than 1.5% of emergency department visits for abdominal pain but has a mortality rate of 55%, due in part to how difficult it can be to diagnose the condition early.
“Acute mesenteric ischemia is a potentially deadly but often underdiagnosed condition. Its early symptoms can resemble common gastrointestinal problems, and current diagnostic tools such as imaging tests are invasive, costly, and often too slow to enable timely treatment,” said senior author Giovanni Traverso, MB, BChir, PhD, MBBCH, a gastroenterologist in the Division of Gastroenterology, Hepatology, and Endoscopy in the Mass General Brigham Department of Medicine. “We aimed to create a faster, safer, and more accessible way to detect this condition before permanent intestinal damage occurs.”
Traverso and his team’s battery-powered swallowable capsule, called FIREFLI (Finding Ischemia via Reflectance of LIght), was inspired by the firefly, which emits light via pH-sensitive luciferase, an enzyme that catalyzes a light-emitting reaction called bioluminescence. FIREFLI generates light after activation by the small intestine’s pH. The emitted light illuminates the surrounding tissue, with ischemic tissue (deprived of oxygen and nutrients) demonstrating significantly lower luminance. These data are then transmitted wirelessly to an external mobile device which could someday allow clinicians to diagnose acute mesenteric ischemia.
In studies conducted in nine pigs, FIREFLI correctly identified acute mesenteric ischemia 90% of the time overall—it was excellent at correctly identifying animals with the condition (98% sensitivity) but was somewhat less effective at ruling out those that didn’t have it (85% specificity), leading to some false positives.
“This work brings together engineering, biology, and medicine to make an invisible medical emergency detectable quickly and noninvasively,” said Traverso. “The approach could enable faster triage in emergency departments, reduce unnecessary invasive testing in patients whose abdominal symptoms are not caused by ischemia, expand access to diagnostic care in clinics that lack advanced imaging technology, and lay the groundwork for future ‘smart’ capsules that combine sensing, wireless communication, and even targeted therapy delivery.”
Authorship: In addition to Traverso, Mass General Brigham authors include J. Chen, A. Alexiev, A. Sergnese, A. Hayward, C. Rosen, N. Shalabi, and S. Owyang. Additional authors include N. Fabian, A. Pettinari, Y. Cai, V. Perepelook, K. Schmidt, A. Guevara, B. Laidlaw, I. Moon, B. Markowitz, I. Ballinger, and Z. Yang.
Disclosures: Complete details of all relationships for profit and not for profit for Traverso can be found at the following link: www.dropbox.com/sh/szi7vnr4a2ajb56/AABs5N5i0q9AfT1IqIJAE-T5a?dl=0.
Funding: This work was funded in part by 1) The Karl van Tassel (1925) Career Development Professorship, Department of Mechanical Engineering, Massachusetts Institute of Technology (MIT). 2) The Division of Gastroenterology, Brigham and Women’s Hospital. 3) Advanced Research Projects Agency for Health (ARPA-H) under Award Number D24AC00040-00. 4) Defense Advanced Research Projects Agency (DARPA) under agreement number FA8650-21-2-7120 awarded to G.T. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing official policies or endorsements, either expressed or implied, of ARPA-H, DARPA, or the US Government. J.C. is supported by the Natural Science and Engineering Research Council of Canada Postgraduate Scholarship-Doctoral. S.O. is supported by the NIH through NIDDK 1F32DK139701-01 and NIDDK T32DK135449.
Paper cited: Chen J et al. “An Ingestible Capsule for Luminance-Based Diagnosis of Mesenteric Ischemia” Science Robotics DOI: 10.1126/scirobotics.adx1367
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Study found which abnormal cells talk to each other in harmful ways and perpetuate lung damage
Scientists are already exploring therapeutic strategies based on this study’s discoveries
Treatments also could help patients with other lung-scarring diseases (COPD, COVID-19, etc.)
CHICAGO --- More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet the reason why this is such a prevalent complication has remained a medical mystery.
Now, a new Northwestern Medicine study has found that, following transplant and in chronic disease states, abnormal cells emerge and “conversations” ...
Very early on in our universe, when it was a seething hot cauldron of energy, particles made of matter and antimatter bubbled into existence in equal proportions. For example, negatively charged electrons were created in the same numbers as their antimatter siblings, positively charged positrons. When the two particles combined, they canceled each other out.
Billions of years later, our world is dominated by matter. Somehow matter "won out" over antimatter, but scientists still do not know how. Now, two of the largest experiments attempting to find answers—projects that focus on subatomic particles called neutrinos—have joined forces.
In a ...
Three copies of chromosome 21 causes Down syndrome (DS), and roughly half of children born each year in the United States with DS—approximately 2,600—also have congenital heart defects (CHDs).
What is not known is exactly why the genes on too many copies of chromosome 21 wreak such devastating effects.
In a new paper published in the journal Nature, a team of scientists, including first and co-corresponding author Sanjeev S. Ranade, PhD, assistant professor in the Center for Cardiovascular and Muscular Diseases and Center for Data Science and Artificial Intelligence at Sanford Burnham Prebys, identify a nuclear ...
About The Study: In this cohort study of more than 1,900 patients in randomized clinical trials (RCTs) for advanced epithelial ovarian cancer, Black and Asian patients were underrepresented compared with the general population estimates in the U.S., and Black patients had worse survival outcomes compared with white and Asian patients, despite having similar progression-free survival. Equitable enrollment in clinical trials ensures access to cutting-edge treatments and can lead to outcomes comparable to those of white counterparts. Sustained efforts to improve RCT diversity remain essential to long-term equity in cancer care and survival.
Corresponding ...
About The Study: In this large national cohort, all adverse pregnancy outcomes except small for gestational age were associated with increased risk for atrial fibrillation up to 46 years later. Women with adverse pregnancy outcomes need early preventive actions and long-term clinical follow-up for timely detection and treatment of cardiovascular disorders related to the development of atrial fibrillation.
Corresponding Author: To contact the corresponding author, Casey Crump, MD, PhD, email casey.crump@uth.tmc.edu.
To access ...
When harmful bacteria that cause food poisoning, such as E. coli, invade through the digestive tract, gut cells usually fight back by pushing infected cells out of the body to stop the infection from spreading.
In a new study published today in Nature, scientists from Genentech, a member of the Roche Group, in collaboration with researchers from Oregon Health & Science University, discovered that a dangerous strain of E. coli — known for causing bloody diarrhea — can block gut this defense, allowing ...
Findings from a randomised and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit for ketamine when added onto standard care for people admitted to hospital for depression. The paper is published in the journal JAMA Psychiatry today [Wednesday 22ndOctober 2025].
The KARMA-Dep (2) Trial involved researchers from St Patrick’s Mental Health Services, Trinity College Dublin, and Queens University Belfast, Ireland. It was led by Declan McLoughlin, Research Professor of Psychiatry at Trinity College Dublin and Consultant Psychiatrist at St Patrick’s Mental Health Services.
Depression ...
Ants have evolved an acute sense of smell, which requires each sensory neuron to choose one scent receptor out of hundreds. In a new study published in Nature, researchers at New York University have discovered what ants use to solve this biological puzzle: a self-regulating system in which choosing one gene physically silences all its neighbors.
A high-stakes sense of smell
Ants communicate via pheromones to hunt, detect outsiders, and determine their role within a colony. Without precise control of olfactory receptors, ant society would unravel. When ants cannot smell, “they stop performing their duties, which leads to anarchy,” explained ...
SAN FRANCISCO—October 22, 2025—Nearly half of all babies born with Down syndrome face congenital heart defects, often involving serious malformations that require surgery in the first months of life.
For decades, scientists have known that having an extra copy of chromosome 21—the genetic cause of Down syndrome—was responsible, but they couldn’t pin down which of its hundreds of genes were key for causing the heart problems.
Now, scientists at Gladstone Institutes have an answer. In a study published in Nature, the researchers leveraged stem cell science and ...
The University of California San Diego School of Medicine’s Centers for Integrative Health has received a five-year, $6.2 million grant from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH) to establish the REACH Center for Translational Science on Whole Person Health.
The three principal investigators are Cassandra Vieten, Ph.D., clinical professor in the Department of Family Medicine at UC San Diego School of Medicine, Gene “Rusty” Kallenberg, ...
